United States
Germany
Japan
United Kingdom
China
PGM3 (NM_015599) Human Tagged ORF Clone Lentiviral Particle
CAT＃: RC201522L3V
- LentiORF®
-
Lenti ORF particles, PGM3 (Myc-DDK tagged) - Human phosphoglucomutase 3 (PGM3), transcript variant 2, 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 8,930.00
Product images
CNY 2,950.00
CNY 1,999.00
CNY 2,700.00
Specifications
| Product Data | |
| Product Name | PGM3 (NM_015599) Human Tagged ORF Clone Lentiviral Particle |
| Synonyms | AGM1; IMD23; PAGM; PGM 3 |
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| ACCN | NM_015599 |
| ORF Size | 1626 bp |
| Sequence Data |
The ORF insert of this clone is exactly the same as(RC201522).
|
| OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
| OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
| Reference Data | |
| RefSeq | NM_015599.1 |
| RefSeq Size | 6107 bp |
| RefSeq ORF | 1629 bp |
| Locus ID | 5238 |
| Domains | PGM_PMM, PGM_PMM_I |
| Protein Pathways | Amino sugar and nucleotide sugar metabolism |
| MW | 59.9 kDa |
| Gene Summary | This gene encodes a member of the phosphohexose mutase family. The encoded protein mediates both glycogen formation and utilization by catalyzing the interconversion of glucose-1-phosphate and glucose-6-phosphate. A non-synonymous single nucleotide polymorphism in this gene may play a role in resistance to diabetic nephropathy and neuropathy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2010] |
Documents
| Product Manuals |
| FAQs |
| SDS |
